Clinical Trial Update: Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family [Phase 1]

View source ↗

Summary

Phase 1 trial comparing biomarker modulation from inhibition of EGFR and/or SRC family kinases in head and neck cancer and non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Pittsburgh | Conditions: Head and Neck Cancer, Non Small Cell Lung Cancer | Phase 1 | Status: COMPLETED